A Bivalent Omicron-Containing Booster Vaccine against Covid-19

BACKGROUND: The safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known. METHODS: In this ongoing, phase 2–3 study, we compared the 50-μg bivalent vaccine mRNA-1273.214 (25 μg each of ancestral Wuhan-Hu-1 and omicron B.1.1.529 [BA.1] spike messenger R...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalkias, Spyros, Harper, Charles, Vrbicky, Keith, Walsh, Stephen R., Essink, Brandon, Brosz, Adam, McGhee, Nichole, Tomassini, Joanne E., Chen, Xing, Chang, Ying, Sutherland, Andrea, Montefiori, David C., Girard, Bethany, Edwards, Darin K., Feng, Jing, Zhou, Honghong, Baden, Lindsey R., Miller, Jacqueline M., Das, Rituparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511634/
https://www.ncbi.nlm.nih.gov/pubmed/36112399
http://dx.doi.org/10.1056/NEJMoa2208343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511634/
https://www.ncbi.nlm.nih.gov/pubmed/36112399
http://dx.doi.org/10.1056/NEJMoa2208343

Ejemplares similares